Clinical Trial Update: Efficacy of Levocetirizine Fourfold Dosage in Chronic Spontaneous Urticaria [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating fourfold dosage of levocetirizine for chronic spontaneous urticaria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spontaneous Urticaria

Drugs mentioned

• Levocetirizine (Levocetirizine)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Chronic Spontaneous Urticaria | Phase 3 | Status: COMPLETED